Published in Experientia on August 15, 1974
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
The role of macrophages in the generation of T-helper cells. II. The genetic control of the macrophage-T-cell interaction for helper cell induction with soluble antigens. J Exp Med (1975) 5.48
Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med (1998) 3.21
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol (2000) 2.73
Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods (1997) 2.44
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41
Unbinding forces of single antibody-antigen complexes correlate with their thermal dissociation rates. Proc Natl Acad Sci U S A (2000) 2.27
Role of macrophages in in vitro induction of T-helper cells. Nature (1975) 1.84
Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev (1995) 1.66
The role of macrophages in the generation of T-helper cells. I. The requirement for macrophages in helper cell induction and characteristics of the macrophage-T cell interaction. Cell Immunol (1975) 1.62
Insulin-like growth factors I and II in fetal and adult bovine serum. Purification, primary structures, and immunological cross-reactivities. J Biol Chem (1986) 1.58
Role of macrophages in the generation of T helper cells. IV. Nature of genetically related factor derived from macrophages incubated with soluble antigens. Eur J Immunol (1976) 1.57
A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia. AIDS (2001) 1.56
Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol (2001) 1.54
In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon. Infect Immun (1986) 1.49
Evidence for D276G and L364I Bcr-Abl mutations in Ph+ leukaemic cells obtained from patients resistant to Imatinib. Leukemia (2005) 1.48
Selection for improved protein stability by phage display. J Mol Biol (1999) 1.46
Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. Radiology (1999) 1.42
Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Eng (1997) 1.37
Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A (1993) 1.33
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res (1999) 1.32
Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci U S A (2001) 1.26
Impairment of cell-mediated immune responses by Pseudomonas aeruginosa. Clin Exp Immunol (1971) 1.24
Nature of T-cell macrophage interaction in helper-cell induction in vitro. II. Two stages of T-helper-cell differentiation analyzed in irradiation and allophenic chimeras. J Exp Med (1979) 1.20
High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Defic Syndr (1999) 1.17
Antibody scFv fragments without disulfide bonds made by molecular evolution. J Mol Biol (1998) 1.17
The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS (1996) 1.14
delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection. Hepatology (1981) 1.12
Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. Biotechniques (1997) 1.12
Crystalline and amorphous gold in chrysiasis. Arch Dermatol Res (1990) 1.11
Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors. Cold Spring Harb Symp Quant Biol (1977) 1.11
Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest (2001) 1.11
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol (2001) 1.10
Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry (2001) 1.10
Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int J Cancer (2000) 1.10
Nature of T cell-macrophage interaction in helper cell induction in vitro. I. Evidence for genetic restriction of T cell-macrophage interactions prior to T cell priming. Eur J Immunol (1978) 1.10
The role of macrophages in the generation of T helper cells. III. Influence of macrophage-derived factors in helper cell induction. Eur J Immunol (1975) 1.09
Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Oncogene (2008) 1.08
Multiple myeloma and HHV8 infection. Blood (1998) 1.08
The behaviour of peptides on reverse-phase supports during high-pressure liquid chromatography. Biochem J (1981) 1.07
Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors. J Biol Chem (2000) 1.07
Is genetically related macrophage factor (GRF) a soluble immune response (Ir) gene product? J Immunol (1979) 1.06
Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol (1998) 1.05
Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase. Biochemistry (1993) 1.05
Comparison of buffers and detection systems for high-pressure liquid chromatography of peptide mixtures. Biochem J (1981) 1.04
A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. J Mol Biol (1997) 1.03
Macrophage-lymphocyte interactions in immune induction. Int Rev Cytol (1979) 1.02
Nature of T cell-macrophage interaction in helper cell induction in vitro. III. Responsiveness of T cells differentiating in irradiation or allophenic chimeras depends on the genotype of the host. J Immunol (1980) 1.00
Affinity and folding properties both influence the selection of antibodies with the selectively infective phage (SIP) methodology. FEBS Lett (1997) 1.00
H-2 complex-linked resistance in murine toxoplasmosis. J Infect Dis (1985) 0.99
Eosinophilia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1997) 0.98
Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J Neuroimmunol (1986) 0.97
Accessory cell-dependent selection of specific T-cell functions. Nature (1983) 0.97
Characterization of accessory cells required for helper T cell induction in vitro: evidence for a phagocytic, Fc-receptor, and Ia-bearing cell type. J Immunol (1980) 0.97
Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer (2013) 0.96
Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets. J Infect Dis (1986) 0.96
Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity. Cell Growth Differ (1990) 0.95
P-element inserts in transgenic flies: a cautionary tale. Heredity (Edinb) (1997) 0.95
Folding nuclei of the scFv fragment of an antibody. Biochemistry (1996) 0.94
Etiology of acute infectious diarrhea in a highly industrialized area of Switzerland. Gastroenterology (1985) 0.94
Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant (2000) 0.94
Progress in experimental intestinal transplantation in small animal models. Acta Gastroenterol Belg (1999) 0.93
Peritoneal reaction to liquid silicone: an experimental study. Graefes Arch Clin Exp Ophthalmol (1987) 0.93
CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC. Eur J Immunol (1992) 0.93
Identification and arrangement of coxsackievirus A1 in muscles of newborn mice. Br J Exp Pathol (1969) 0.93
Expression of functional trk tyrosine kinase receptors after T cell activation. J Immunol (1994) 0.91
High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol (1997) 0.90
Chemical modification of peptides by hydrazine. Biochem J (1981) 0.90
Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries. J Mol Biol (2001) 0.90
Multiple organ manifestations in thromboangiitis obliterans (Buerger's disease). A case report. Angiology (1996) 0.89
Ia-bearing bone marrow-cultured macrophages induce antigen-specific helper T cells for antibody synthesis. J Immunol (1979) 0.89
Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment. Cell Oncol (Dordr) (2011) 0.88
Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. J Med Virol (2001) 0.87
The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease. Int Rev Immunol (1999) 0.87
Expression of cellular effector functions and production of reactive nitrogen intermediates: a comparative study including T lymphocytes, T-like cells, neutrophil granulocytes, and mononuclear phagocytes. Cell Immunol (1990) 0.87
Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells. Br J Cancer (2012) 0.87
The first case report of the use of a zoom videoendoscope for the evaluation of small bowel graft mucosa in a human after intestinal transplantation. Gastrointest Endosc (1999) 0.87
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. Br J Cancer (2006) 0.86
Coxsackievirus infection in skeletal muscles of mice. An electron microscopic study. II. Appearance and fate of virus progeny. Arch Gesamte Virusforsch (1970) 0.86
Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea. Arch Dermatol (1995) 0.86
Down-modulation of CD4+ T helper type 2 and type 0 cells by T helper type 1 cells via Fas/Fas-ligand interaction. Eur J Immunol (1995) 0.86
Mechanisms of chronic rejection. Curr Opin Immunol (2000) 0.86
Sandwich-dot immunobinding assay (Sandwich-DIA), a new immunological method for the detection of diphtheria toxin. Zentralbl Bakteriol (1990) 0.86
Two-gene control of T-helper cell induction. Nature (1976) 0.86
Reproducing the natural evolution of protein structural features with the selectively infective phage (SIP) technology. The kink in the first strand of antibody kappa domains. J Mol Biol (1998) 0.85
Ischemia-reperfusion injury. Transplant Proc (2001) 0.85
Graft-versus-leukaemia activity can be predicted by natural cytotoxicity against leukaemia cells. Br J Haematol (1996) 0.85
Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection? Eur Surg Res (2009) 0.85
Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study. J Infect Dis (1999) 0.84
Fructose-1,6-bisphosphate aldolase from Drosophila melanogaster: primary structure analysis, secondary structure prediction, and comparison with vertebrate aldolases. Arch Biochem Biophys (1988) 0.84
Evaluation of Ia+ tumor cell lines and peritoneal exudate macrophages as accessory cells: differential requirements for the activation of certain T cell functions. J Immunol (1983) 0.84
The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains. J Mol Biol (2001) 0.84
Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest (1997) 0.84
[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH]. Schweiz Med Wochenschr (1996) 0.84
The role of macrophages in the generation of T helper cells. V. Evidence for differential activation of short-lived T1 and long-lived T2 lymphocytes by the macrophage factors GRF and NMF. J Immunol (1977) 0.83
Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies. Leukemia (2005) 0.83
Spleen and lymph node cell populations, in vitro cell proliferation and interferon-gamma production during the primary immune response to Toxoplasma gondii. Parasite Immunol (1986) 0.83
Interaction of Mycoplasma pneumoniae with alveolar macrophages: viability of adherent and ingested mycoplasmas. Infect Immun (1979) 0.83
Persistent organic pollutants (PCDD/Fs, dioxin-like PCBs, marker PCBs, and PBDEs) in health supplements on the Spanish market. Chemosphere (2010) 0.82
Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer--indications for anti-TNF-α agents in cancer treatment. Anal Cell Pathol (Amst) (2010) 0.82